Adaptive Biotechnologies (ADPT) Competitors $8.10 -0.16 (-1.94%) Closing price 03/3/2025 04:00 PM EasternExtended Trading$8.10 0.00 (0.00%) As of 03/3/2025 06:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends ADPT vs. TGTX, SWTX, RARE, OGN, PTCT, ADMA, RNA, ZLAB, BHVN, and ALVOShould you be buying Adaptive Biotechnologies stock or one of its competitors? The main competitors of Adaptive Biotechnologies include TG Therapeutics (TGTX), SpringWorks Therapeutics (SWTX), Ultragenyx Pharmaceutical (RARE), Organon & Co. (OGN), PTC Therapeutics (PTCT), ADMA Biologics (ADMA), Avidity Biosciences (RNA), Zai Lab (ZLAB), Biohaven (BHVN), and Alvotech (ALVO). These companies are all part of the "pharmaceutical products" industry. Adaptive Biotechnologies vs. TG Therapeutics SpringWorks Therapeutics Ultragenyx Pharmaceutical Organon & Co. PTC Therapeutics ADMA Biologics Avidity Biosciences Zai Lab Biohaven Alvotech Adaptive Biotechnologies (NASDAQ:ADPT) and TG Therapeutics (NASDAQ:TGTX) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their community ranking, valuation, media sentiment, dividends, analyst recommendations, risk, earnings, profitability and institutional ownership. Does the MarketBeat Community favor ADPT or TGTX? TG Therapeutics received 561 more outperform votes than Adaptive Biotechnologies when rated by MarketBeat users. Likewise, 76.33% of users gave TG Therapeutics an outperform vote while only 57.74% of users gave Adaptive Biotechnologies an outperform vote. CompanyUnderperformOutperformAdaptive BiotechnologiesOutperform Votes9757.74% Underperform Votes7142.26% TG TherapeuticsOutperform Votes65876.33% Underperform Votes20423.67% Which has more risk & volatility, ADPT or TGTX? Adaptive Biotechnologies has a beta of 1.5, suggesting that its stock price is 50% more volatile than the S&P 500. Comparatively, TG Therapeutics has a beta of 2.26, suggesting that its stock price is 126% more volatile than the S&P 500. Does the media refer more to ADPT or TGTX? In the previous week, TG Therapeutics had 26 more articles in the media than Adaptive Biotechnologies. MarketBeat recorded 28 mentions for TG Therapeutics and 2 mentions for Adaptive Biotechnologies. Adaptive Biotechnologies' average media sentiment score of 1.78 beat TG Therapeutics' score of 0.74 indicating that Adaptive Biotechnologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Adaptive Biotechnologies 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive TG Therapeutics 10 Very Positive mention(s) 2 Positive mention(s) 11 Neutral mention(s) 0 Negative mention(s) 2 Very Negative mention(s) Positive Do analysts prefer ADPT or TGTX? Adaptive Biotechnologies presently has a consensus price target of $9.10, suggesting a potential upside of 12.35%. TG Therapeutics has a consensus price target of $40.67, suggesting a potential upside of 18.15%. Given TG Therapeutics' stronger consensus rating and higher probable upside, analysts clearly believe TG Therapeutics is more favorable than Adaptive Biotechnologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Adaptive Biotechnologies 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80TG Therapeutics 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.83 Which has preferable valuation and earnings, ADPT or TGTX? TG Therapeutics has higher revenue and earnings than Adaptive Biotechnologies. TG Therapeutics is trading at a lower price-to-earnings ratio than Adaptive Biotechnologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAdaptive Biotechnologies$178.96M6.68-$159.49M-$1.09-7.43TG Therapeutics$264.79M20.23$12.67M-$0.10-344.20 Do institutionals & insiders have more ownership in ADPT or TGTX? 99.2% of Adaptive Biotechnologies shares are held by institutional investors. Comparatively, 58.6% of TG Therapeutics shares are held by institutional investors. 6.2% of Adaptive Biotechnologies shares are held by insiders. Comparatively, 10.5% of TG Therapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Is ADPT or TGTX more profitable? TG Therapeutics has a net margin of -5.42% compared to Adaptive Biotechnologies' net margin of -89.12%. TG Therapeutics' return on equity of -8.32% beat Adaptive Biotechnologies' return on equity.Company Net Margins Return on Equity Return on Assets Adaptive Biotechnologies-89.12% -64.65% -26.45% TG Therapeutics -5.42%-8.32%-3.40% SummaryTG Therapeutics beats Adaptive Biotechnologies on 15 of the 18 factors compared between the two stocks. Get Adaptive Biotechnologies News Delivered to You Automatically Sign up to receive the latest news and ratings for ADPT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ADPT vs. The Competition Export to ExcelMetricAdaptive BiotechnologiesBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.20B$3.08B$5.81B$8.43BDividend YieldN/A1.51%4.76%3.97%P/E Ratio-7.4328.6624.9419.24Price / Sales6.68403.85376.51110.22Price / CashN/A168.6838.0534.58Price / Book5.913.487.374.28Net Income-$159.49M-$71.55M$3.18B$247.04M7 Day Performance-3.80%-5.00%-2.91%-3.25%1 Month Performance9.91%-10.68%-6.80%-6.55%1 Year Performance103.01%-22.37%12.66%4.01% Adaptive Biotechnologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ADPTAdaptive Biotechnologies3.589 of 5 stars$8.10-1.9%$9.10+12.3%+101.0%$1.20B$178.96M-7.43790Positive NewsTGTXTG Therapeutics3.9364 of 5 stars$29.04-6.0%$40.67+40.1%+91.6%$4.52B$264.79M-290.32290Earnings ReportOptions VolumeNews CoverageSWTXSpringWorks Therapeutics2.6348 of 5 stars$56.58-2.9%$71.50+26.4%+4.5%$4.21B$191.59M-16.26230Short Interest ↓RAREUltragenyx Pharmaceutical4.5398 of 5 stars$41.81-1.8%$93.50+123.6%-23.2%$3.89B$560.23M-6.631,276Insider TradeOGNOrganon & Co.4.8863 of 5 stars$15.08-0.9%$20.80+38.0%-18.3%$3.88B$6.40B4.5310,000Positive NewsPTCTPTC Therapeutics3.7228 of 5 stars$50.01-1.3%$58.85+17.7%+65.5%$3.86B$900.66M-8.421,410Analyst RevisionADMAADMA Biologics3.0855 of 5 stars$15.52-2.1%$21.25+37.0%+186.8%$3.67B$382.81M55.41530Positive NewsRNAAvidity Biosciences1.121 of 5 stars$30.54-1.9%$65.80+115.4%+45.3%$3.64B$10.12M-10.61190Earnings ReportAnalyst RevisionGap DownZLABZai Lab2.4705 of 5 stars$32.98-2.4%$55.00+66.8%+50.4%$3.61B$355.75M-11.902,175Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageHigh Trading VolumeBHVNBiohaven3.4763 of 5 stars$35.46-3.9%$63.15+78.1%-35.5%$3.59BN/A-3.79239Earnings ReportUpcoming EarningsNews CoveragePositive NewsALVOAlvotech2.2676 of 5 stars$11.87-3.4%$18.00+51.7%-29.6%$3.58B$93.38M-6.411,026 Related Companies and Tools Related Companies TG Therapeutics Competitors SpringWorks Therapeutics Competitors Ultragenyx Pharmaceutical Competitors Organon & Co. Competitors PTC Therapeutics Competitors ADMA Biologics Competitors Avidity Biosciences Competitors Zai Lab Competitors Biohaven Competitors Alvotech Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ADPT) was last updated on 3/4/2025 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredLeaked Trump video exposes his secret stocksTen investments secretly owned by Trump’s biggest backers. Ten investments intrinsically tied to the polici...Porter & Company | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredTrump’s Victory Could Spark Major Gains for Gold – Don’t Miss Out This "Patriot's Tax Shield" lets you defend your wealth with real, solid gold. Our exclusive, free wealth pr...American Alternative | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adaptive Biotechnologies Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Adaptive Biotechnologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ADPT Stock Alerts